Full Text View
Tabular View
No Study Results Posted
Related Studies
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
This study has been suspended.
First Received: January 3, 2008   Last Updated: November 11, 2009   History of Changes
Sponsor: Pfizer
Information provided by: Pfizer
ClinicalTrials.gov Identifier: NCT00596830
  Purpose

Determine whether the addition of CP 751,871 in combination with paclitaxel plus carboplatin prolongs survival in patients with locally advanced (Stage IIIB with pleural effusion) or metastatic (Stage IV or recurrent) NSCLC of non adenocarcinoma histology.


Condition Intervention Phase
Carcinoma, Squamous Cell
Carcinoma, Adenosquamous
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Drug: CP-751,871 + Carboplatin +Paclitaxel
Drug: Carboplatin + Paclitaxel
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study
Official Title: Randomized, Open Label, Phase III Trial Of CP- 751,871 In Combination With Paclitaxel And Carboplatin Versus Paclitaxel And Carboplatin In Patients With Non Small Cell Lung Cancer

Resource links provided by NLM:


Further study details as provided by Pfizer:

Primary Outcome Measures:
  • Overall Survival (OS) [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Overall objective response rate (ORR) [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • Progression Free Survival (PFS) [ Time Frame: 2.5 years ] [ Designated as safety issue: No ]
  • Overall safety profile [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]
  • Patient reported outcomes (PROs) [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]
  • Pharmacokinetics of CP 751,871 [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]
  • Anti drug antibody occurrence [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]
  • Change in serum IGF1 levels [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 820
Study Start Date: March 2008
Estimated Study Completion Date: July 2011
Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
Patients in Arm A will receive CP-751, 871 in combination with paclitaxel and carboplatin intravenously every 21 days for up to six cycles.`
Drug: CP-751,871 + Carboplatin +Paclitaxel

CP 751,871 is a potent and selective fully human monoclonal antibody against the insulin like growth factor 1 receptor (IGF-1R).

Carboplatin is a standard chemotherapeutic agent used in patients with lung cancer.

Paclitaxel is a standard chemotherapeutic agent used in patients with lung cancer.

B: Active Comparator
Patient in Arm B will receive paclitaxel and carboplatin intravenously every 21 days for up to six cycles.
Drug: Carboplatin + Paclitaxel
Carboplatin is a standard chemotherapeutic agent used in patients with lung cancer

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Confirmed diagnosis of non small cell lung cancer with a primary histology of predominantly squamous cell, large cell or adenosquamous carcinoma.
  • Advanced NSCLC with documented Stage IIIB (with pleural effusion) or Stage IV or recurrent disease.
  • No prior systemic treatment for NSCLC, except for adjuvant chemotherapy. Adjuvant chemotherapy must have completed for greater than or equal to 12 months prior to randomization.
  • Prior surgery or radiation therapy is permitted if completed at least 3 weeks prior to randomization and all acute toxicities have resolved.
  • ECOG performance status (PS) 0 or 1.

Exclusion Criteria:

  • Patients with symptomatic central nervous system (CNS) metastases are not permitted.
  • Patients requiring chronic steroid use or patients with uncontrolled diabetes are not permitted.
  • Patients with other active cancer types are not permitted.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00596830

  Hide Study Locations
Locations
United States, Alabama
Pfizer Investigational Site
Florence, Alabama, United States, 35630
Pfizer Investigational Site
Muscle Shoals, Alabama, United States, 35661
Pfizer Investigational Site
Huntsville, Alabama, United States, 35805
United States, Arizona
Pfizer Investigational Site
Phoenix, Arizona, United States, 85012
Pfizer Investigational Site
Scottsdale, Arizona, United States, 85258
United States, Arkansas
Pfizer Investigational Site
Fort Smith, Arkansas, United States, 72903
Pfizer Investigational Site
Hot Springs, Arkansas, United States, 71913
United States, California
Pfizer Investigational Site
Mather, California, United States, 95655
Pfizer Investigational Site
Sacramento, California, United States, 95817
Pfizer Investigational Site
Loma Linda, California, United States, 92354
United States, Colorado
Pfizer Investigational Site
Aurora, Colorado, United States, 80012
Pfizer Investigational Site
Denver, Colorado, United States, 80205
Pfizer Investigational Site
Colorado Springs, Colorado, United States, 80907
Pfizer Investigational Site
Colorado Springs, Colorado, United States, 80909
Pfizer Investigational Site
Denver, Colorado, United States, 80218
Pfizer Investigational Site
Denver, Colorado, United States, 80220
Pfizer Investigational Site
Lakewood, Colorado, United States, 80228
Pfizer Investigational Site
Littleton, Colorado, United States, 80120
Pfizer Investigational Site
Lone Tree, Colorado, United States, 80124
Pfizer Investigational Site
Longmont, Colorado, United States, 80501
Pfizer Investigational Site
Parker, Colorado, United States, 80138
Pfizer Investigational Site
Thornton, Colorado, United States, 80260
Pfizer Investigational Site
Boulder, Colorado, United States, 80303
Pfizer Investigational Site
Colorado Springs, Colorado, United States, 80907
United States, Connecticut
Pfizer Investigational Site
Norwich, Connecticut, United States, 06360
Pfizer Investigational Site
Norwalk, Connecticut, United States, 06856
United States, District of Columbia
Pfizer Investigational Site
Washington, District of Columbia, United States, 20007
Pfizer Investigational Site
Washington, District of Columbia, United States, 20007-2197
United States, Florida
Pfizer Investigational Site
Hollywood, Florida, United States, 33021
Pfizer Investigational Site
Pembroke Pines, Florida, United States, 33028
Pfizer Investigational Site
Jacksonville, Florida, United States, 32205
Pfizer Investigational Site
Jacksonville, Florida, United States, 32207
Pfizer Investigational Site
Jacksonville, Florida, United States, 32256
Pfizer Investigational Site
Jacksonville, Florida, United States, 32258
Pfizer Investigational Site
Pensacola, Florida, United States, 32514
Pfizer Investigational Site
Orlando, Florida, United States, 32803
Pfizer Investigational Site
Port St. Lucie, Florida, United States, 34952
Pfizer Investigational Site
Lake City, Florida, United States, 32024
Pfizer Investigational Site
Lake City, Florida, United States, 32055
Pfizer Investigational Site
Boynton Beach, Florida, United States, 33426
Pfizer Investigational Site
Lake Worth, Florida, United States, 33461
Pfizer Investigational Site
Hudson, Florida, United States, 34667
Pfizer Investigational Site
New Port Richey, Florida, United States, 34655
Pfizer Investigational Site
Spring Hill, Florida, United States, 34608
Pfizer Investigational Site
Lakeland, Florida, United States, 33805
Pfizer Investigational Site
Pensacola, Florida, United States, 32504
Pfizer Investigational Site
Orlando, Florida, United States, 32804
Pfizer Investigational Site
Fort Lauderdale, Florida, United States, 33308
Pfizer Investigational Site
Miami, Florida, United States, 33133
United States, Georgia
Pfizer Investigational Site
Atlanta, Georgia, United States, 30341
Pfizer Investigational Site
Atlanta, Georgia, United States, 30342
Pfizer Investigational Site
Decatur, Georgia, United States, 30033
Pfizer Investigational Site
Snellville, Georgia, United States, 30078
Pfizer Investigational Site
Marietta, Georgia, United States, 30060
Pfizer Investigational Site
Atlanta, Georgia, United States, 30318
Pfizer Investigational Site
Duluth, Georgia, United States, 30096
Pfizer Investigational Site
Lawrenceville, Georgia, United States, 30045
Pfizer Investigational Site
Macon, Georgia, United States, 31217
Pfizer Investigational Site
Conyers, Georgia, United States, 30094
Pfizer Investigational Site
Cumming, Georgia, United States, 30041
Pfizer Investigational Site
Roswell, Georgia, United States, 30076
Pfizer Investigational Site
Stockbridge, Georgia, United States, 30281
United States, Idaho
Pfizer Investigational Site
Boise, Idaho, United States, 83712
Pfizer Investigational Site
Fruitland, Idaho, United States, 83619
Pfizer Investigational Site
Meridian, Idaho, United States, 83642
Pfizer Investigational Site
Nampa, Idaho, United States, 83686
Pfizer Investigational Site
Twin Falls, Idaho, United States, 83301
Pfizer Investigational Site
Coeur D' Alene, Idaho, United States, 83814
United States, Illinois
Pfizer Investigational Site
Chicago, Illinois, United States, 60637
Pfizer Investigational Site
Aurora, Illinois, United States, 60504
Pfizer Investigational Site
Aurora, Illinois, United States, 61342
Pfizer Investigational Site
Arlington Heights, Illinois, United States, 60005
Pfizer Investigational Site
Elk Grove Village, Illinois, United States, 60007
Pfizer Investigational Site
Galesburg, Illinois, United States, 61401
Pfizer Investigational Site
Skokie, Illinois, United States, 60076
Pfizer Investigational Site
Winfield, Illinois, United States, 60190
United States, Indiana
Pfizer Investigational Site
Avon, Indiana, United States, 46123
Pfizer Investigational Site
Beech Grove, Indiana, United States, 46107
Pfizer Investigational Site
Indianapolis, Indiana, United States, 46237
Pfizer Investigational Site
Indianapolis, Indiana, United States, 46260
Pfizer Investigational Site
Mooresville, Indiana, United States, 46158
Pfizer Investigational Site
Mooresville, Indiana, United States, 46158-1737
Pfizer Investigational Site
Hobart, Indiana, United States, 46342
Pfizer Investigational Site
Hobart, Indiana, United States, 46432
Pfizer Investigational Site
Munster, Indiana, United States, 46321
United States, Iowa
Pfizer Investigational Site
Cedar Rapids, Iowa, United States, 52402
United States, Kansas
Pfizer Investigational Site
Kansas City, Kansas, United States, 66112
Pfizer Investigational Site
Overland Park, Kansas, United States, 66210
United States, Kentucky
Pfizer Investigational Site
Louisville, Kentucky, United States, 40202
Pfizer Investigational Site
Louisville, Kentucky, United States, 40207
United States, Louisiana
Pfizer Investigational Site
New Orleans, Louisiana, United States, 70121
Pfizer Investigational Site
New Orleans, Louisiana, United States, 70112-2699
United States, Maryland
Pfizer Investigational Site
Baltimore, Maryland, United States, 21237
Pfizer Investigational Site
Baltimore, Maryland, United States, 21225
Pfizer Investigational Site
Bethesda, Maryland, United States, 20817
United States, Massachusetts
Pfizer Investigational Site
Lawrence, Massachusetts, United States, 01842
Pfizer Investigational Site
Quincy, Massachusetts, United States, 02169
Pfizer Investigational Site
Stoneham, Massachusetts, United States, 02180
Pfizer Investigational Site
Weymouth, Massachusetts, United States, 02189
Pfizer Investigational Site
Worcester, Massachusetts, United States, 01605
Pfizer Investigational Site
Boston, Massachusetts, United States, 02114
Pfizer Investigational Site
Boston, Massachusetts, United States, 02115
Pfizer Investigational Site
Boston, Massachusetts, United States, 02215
United States, Michigan
Pfizer Investigational Site
Detroit, Michigan, United States, 48201
Pfizer Investigational Site
Farmington Hills, Michigan, United States, 48334
Pfizer Investigational Site
St. Joseph, Michigan, United States, 49085
Pfizer Investigational Site
Petoskey, Michigan, United States, 49770
United States, Minnesota
Pfizer Investigational Site
St. Louis Park, Minnesota, United States, 55416
Pfizer Investigational Site
St. Louis Park, Minnesota, United States, 55426
Pfizer Investigational Site
Burnsville, Minnesota, United States, 55337
Pfizer Investigational Site
Woodbury, Minnesota, United States, 55125
Pfizer Investigational Site
Maplewood, Minnesota, United States, 55109
Pfizer Investigational Site
Minneapolis, Minnesota, United States, 55404
Pfizer Investigational Site
St. Paul, Minnesota, United States, 55102
Pfizer Investigational Site
Edina, Minnesota, United States, 55435
United States, Mississippi
Pfizer Investigational Site
Columbus, Mississippi, United States, 39705
Pfizer Investigational Site
Corinth, Mississippi, United States, 38834
Pfizer Investigational Site
Tupelo, Mississippi, United States, 38801
Pfizer Investigational Site
New Albany, Mississippi, United States, 38652
Pfizer Investigational Site
Oxford, Mississippi, United States, 38655
Pfizer Investigational Site
Southaven, Mississippi, United States, 38671
United States, Missouri
Pfizer Investigational Site
Kansas City, Missouri, United States, 64111
Pfizer Investigational Site
Kansas City, Missouri, United States, 64131
Pfizer Investigational Site
Kansas City, Missouri, United States, 64154
Pfizer Investigational Site
Lee's Summit, Missouri, United States, 64064
United States, Nebraska
Pfizer Investigational Site
Lincoln, Nebraska, United States, 68506
Pfizer Investigational Site
Omaha, Nebraska, United States, 68105
Pfizer Investigational Site
Lincoln, Nebraska, United States, 68510
Pfizer Investigational Site
Lincoln, Nebraska, United States, 68516
Pfizer Investigational Site
Grand Island, Nebraska, United States, 68803
Pfizer Investigational Site
Kearney, Nebraska, United States, 68847
United States, Nevada
Pfizer Investigational Site
Las Vegas, Nevada, United States, 89102
Pfizer Investigational Site
Las Vegas, Nevada, United States, 89106
United States, New Hampshire
Pfizer Investigational Site
Lebanon, New Hampshire, United States, 03756-0001
Pfizer Investigational Site
Manchester, New Hampshire, United States, 03102
United States, New York
Pfizer Investigational Site
Lake Success, New York, United States, 11042
Pfizer Investigational Site
Manhasset, New York, United States, 11030
Pfizer Investigational Site
New Hyde Park, New York, United States, 11040
Pfizer Investigational Site
Oneida, New York, United States, 13421
Pfizer Investigational Site
Oswego, New York, United States, 13126
Pfizer Investigational Site
Syracuse, New York, United States, 13210
Pfizer Investigational Site
Syracuse, New York, United States, 13210-2306
United States, North Carolina
Pfizer Investigational Site
Burlington, North Carolina, United States, 27215
Pfizer Investigational Site
Durham, North Carolina, United States, 27704
United States, Ohio
Pfizer Investigational Site
Canton, Ohio, United States, 44718
Pfizer Investigational Site
Dover, Ohio, United States, 44622
Pfizer Investigational Site
Cleveland, Ohio, United States, 44195
United States, Oklahoma
Pfizer Investigational Site
Norman, Oklahoma, United States, 73071
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States, 73102
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States, 73109
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States, 73112
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States, 73120
Pfizer Investigational Site
Tulsa, Oklahoma, United States, 74104
Pfizer Investigational Site
Tulsa, Oklahoma, United States, 74133
Pfizer Investigational Site
Tulsa, Oklahoma, United States, 74136
United States, Pennsylvania
Pfizer Investigational Site
Allentown, Pennsylvania, United States, 18104
Pfizer Investigational Site
McKeesport, Pennsylvania, United States, 15132
Pfizer Investigational Site
Clairton, Pennsylvania, United States, 15025
Pfizer Investigational Site
Greensburg, Pennsylvania, United States, 15601
Pfizer Investigational Site
Johnstown, Pennsylvania, United States, 15901
Pfizer Investigational Site
Bethlehem, Pennsylvania, United States, 18015
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States, 15215
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States, 15232
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States, 15237
Pfizer Investigational Site
Wexford, Pennsylvania, United States, 15090
Pfizer Investigational Site
Philadelphia, Pennsylvania, United States, 19104
Pfizer Investigational Site
Philadelphia, Pennsylvania, United States, 19106
Pfizer Investigational Site
Radnor, Pennsylvania, United States, 19087
Pfizer Investigational Site
Sayre, Pennsylvania, United States, 18840
United States, South Carolina
Pfizer Investigational Site
Columbia, South Carolina, United States, 29203
Pfizer Investigational Site
Sumter, South Carolina, United States, 29150
United States, Tennessee
Pfizer Investigational Site
Germantown, Tennessee, United States, 38138
Pfizer Investigational Site
Bartlett, Tennessee, United States, 38133
Pfizer Investigational Site
Collierville, Tennessee, United States, 38017
Pfizer Investigational Site
Memphis, Tennessee, United States, 38119
Pfizer Investigational Site
Memphis, Tennessee, United States, 38120
Pfizer Investigational Site
Knoxville, Tennessee, United States, 37909
Pfizer Investigational Site
Knoxville, Tennessee, United States, 37916
Pfizer Investigational Site
Knoxville, Tennessee, United States, 37932
Pfizer Investigational Site
Maryville, Tennessee, United States, 37804
Pfizer Investigational Site
Knoxville, Tennessee, United States, 37920
United States, Texas
Pfizer Investigational Site
Grapevine, Texas, United States, 76051
Pfizer Investigational Site
Irving, Texas, United States, 75063
Pfizer Investigational Site
Houston, Texas, United States, 77030
Pfizer Investigational Site
San Antonio, Texas, United States, 78229
Pfizer Investigational Site
Irving, Texas, United States, 75063
Pfizer Investigational Site
Southlake, Texas, United States, 76092
Pfizer Investigational Site
Fort Worth, Texas, United States, 76177
Pfizer Investigational Site
Fort Worth, Texas, United States, 76177
Pfizer Investigational Site
Dallas, Texas, United States, 75230-2510
Pfizer Investigational Site
Austin, Texas, United States, 78731
Pfizer Investigational Site
Longview, Texas, United States, 75601
Pfizer Investigational Site
Fort Worth, Texas, United States, 76111
Pfizer Investigational Site
Sugar Land, Texas, United States, 77479
Pfizer Investigational Site
Austin, Texas, United States, 78705
Pfizer Investigational Site
Plano, Texas, United States, 75075-7787
Pfizer Investigational Site
Austin, Texas, United States, 78745
Pfizer Investigational Site
Austin, Texas, United States, 78758
Pfizer Investigational Site
Austin, Texas, United States, 78759-5249
Pfizer Investigational Site
Round Rock, Texas, United States, 78665
Pfizer Investigational Site
Round Rock, Texas, United States, 78681
Pfizer Investigational Site
San Marcos, Texas, United States, 78666
Pfizer Investigational Site
Tyler, Texas, United States, 75702
United States, Utah
Pfizer Investigational Site
Bountiful, Utah, United States, 84010
Pfizer Investigational Site
Layton, Utah, United States, 84041
Pfizer Investigational Site
Murray, Utah, United States, 84157
Pfizer Investigational Site
Provo, Utah, United States, 84604
Pfizer Investigational Site
Salt Lake City, Utah, United States, 84102
Pfizer Investigational Site
Salt Lake City, Utah, United States, 84106
Pfizer Investigational Site
West Valley City, Utah, United States, 84120
United States, Virginia
Pfizer Investigational Site
Gloucester, Virginia, United States, 23061
Pfizer Investigational Site
Newport News, Virginia, United States, 23601
Pfizer Investigational Site
Williamsburg, Virginia, United States, 23185
Pfizer Investigational Site
Woodbridge, Virginia, United States, 22191
Pfizer Investigational Site
Fairfax, Virginia, United States, 22031
Pfizer Investigational Site
Fairfax, Virginia, United States, 22033
Pfizer Investigational Site
Gainesville, Virginia, United States, 20155
Pfizer Investigational Site
Leesburg, Virginia, United States, 20176
Pfizer Investigational Site
Arlington, Virginia, United States, 22205
Pfizer Investigational Site
Christiansburg, Virginia, United States, 24073
Pfizer Investigational Site
Roanoke, Virginia, United States, 24014
Pfizer Investigational Site
Salem, Virginia, United States, 24153
Pfizer Investigational Site
Wytheville, Virginia, United States, 24382
United States, Washington
Pfizer Investigational Site
Seattle, Washington, United States, 98104
Pfizer Investigational Site
Seattle, Washington, United States, 98122
Pfizer Investigational Site
Seattle, Washington, United States, 98133
Pfizer Investigational Site
Spokane, Washington, United States, 99216
Pfizer Investigational Site
Spokane, Washington, United States, 99218
Pfizer Investigational Site
Spokane Valley, Washington, United States, 99202
Pfizer Investigational Site
Spokane, Washington, United States, 99218
United States, West Virginia
Pfizer Investigational Site
Wheeling, West Virginia, United States, 26003-6300
Pfizer Investigational Site
Morgantown, West Virginia, United States, 26506-9162
Australia, New South Wales
Pfizer Investigational Site
Albury, New South Wales, Australia, 2640
Pfizer Investigational Site
Port Macquarie, New South Wales, Australia, 2444
Australia, Victoria
Pfizer Investigational Site
Geelong, Victoria, Australia, 3220
Pfizer Investigational Site
Wodonga, Victoria, Australia, 3690
Austria
Pfizer Investigational Site
Linz, Austria, A-4010
Pfizer Investigational Site
Innsbruck, Austria, A-6020
Pfizer Investigational Site
Wien, Austria, A-1090
Brazil, RJ
Pfizer Investigational Site
Rio de Janeiro, RJ, Brazil, 20231 -050
Brazil, RS
Pfizer Investigational Site
Porto Alegre, RS, Brazil, 90035-903
Brazil, SP
Pfizer Investigational Site
Sao Paulo, SP, Brazil, 01224-010
Bulgaria
Pfizer Investigational Site
Varna, Bulgaria, 9000
Pfizer Investigational Site
Sofia, Bulgaria, 1233
Pfizer Investigational Site
Sofia, Bulgaria, 1756
Pfizer Investigational Site
Sofia, Bulgaria, 1527
Canada, Alberta
Pfizer Investigational Site
Edmonton, Alberta, Canada, T6G 1Z2
Canada, Ontario
Pfizer Investigational Site
Oshawa, Ontario, Canada, L1G 2B9
Canada, Quebec
Pfizer Investigational Site
Montreal, Quebec, Canada, H3T 1E2
Pfizer Investigational Site
Greenfield Park, Quebec, Canada, J4V 2H1
Pfizer Investigational Site
Levis, Quebec, Canada, G6V 3Z1
Czech Republic
Pfizer Investigational Site
Praha 8, Czech Republic, 180 81
Pfizer Investigational Site
Pribram V, Czech Republic, 261 95
Pfizer Investigational Site
Nova Ves Pod Plesi, Czech Republic, 262 04
Pfizer Investigational Site
Pribram I, Czech Republic, 261 26
Finland
Pfizer Investigational Site
Helsinki, Finland, 00290
Pfizer Investigational Site
Pori, Finland, 28500
France
Pfizer Investigational Site
Lyon Cedex 04, France, 69317
Pfizer Investigational Site
Saint Herblain Cedex, France, 44805
Pfizer Investigational Site
Dijon, France, 21079
Pfizer Investigational Site
Rennes Cedex 9, France, 35033
Pfizer Investigational Site
Clermond-Ferrand Cedex 01, France, 63003
Pfizer Investigational Site
Caen Cedex, France, 14033
Pfizer Investigational Site
Saint Pierre La Réunion Cedex, France, 97448
Pfizer Investigational Site
Nantes Cedex 2, France, 44202
Pfizer Investigational Site
Caen Cedex 05, France, 14076
Germany
Pfizer Investigational Site
Oldenburg, Germany, 26133
Pfizer Investigational Site
Grosshansdorf, Germany, 22927
Pfizer Investigational Site
Mainz, Germany, 55131
Pfizer Investigational Site
Leipzig, Germany, 04207
Pfizer Investigational Site
Karlsruhe, Germany, 76137
Pfizer Investigational Site
Berlin, Germany, 14165
Pfizer Investigational Site
Gauting, Germany, 82131
Greece
Pfizer Investigational Site
Athens, Greece, 11527
Pfizer Investigational Site
Thessaloniki, Greece, 56429
Pfizer Investigational Site
Athens, Greece, 10676
Greece, Pylaia
Pfizer Investigational Site
Thessaloniki, Pylaia, Greece, 57001
Hong Kong
Pfizer Investigational Site
Shatin, New Territories, Hong Kong
Pfizer Investigational Site
Kowloon, Hong Kong, 0
Pfizer Investigational Site
Tuen Mun, Hong Kong
Hungary
Pfizer Investigational Site
Szombathely, Hungary, 9700
Pfizer Investigational Site
Torokbalint, Hungary, 2045
Pfizer Investigational Site
Szekesfehervar, Hungary, 8000
Pfizer Investigational Site
Deszk, Hungary, 6772
Pfizer Investigational Site
Budapest, Hungary, 1525
India
Pfizer Investigational Site
New Delhi, India, 110 030
India, GUJARAT
Pfizer Investigational Site
Navrangpura / Ahmedabad, GUJARAT, India, 380 009
India, Karnataka
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 078
India, Maharashtra
Pfizer Investigational Site
Mumbai, Maharashtra, India, 400 012
Pfizer Investigational Site
Nagpur, Maharashtra, India, 440012
Ireland
Pfizer Investigational Site
Dublin, Ireland, 9
Pfizer Investigational Site
Dublin 24, Ireland
Italy
Pfizer Investigational Site
Orbassano (to), Italy, 10043
Pfizer Investigational Site
Genova, Italy, 16132
Pfizer Investigational Site
Padova, Italy, 35128
Pfizer Investigational Site
Roma, Italy, 00152
Japan
Pfizer Investigational Site
Koto-ku, Tokyo, Japan
Pfizer Investigational Site
Fukuoka, Japan
Pfizer Investigational Site
Osaka, Japan
Japan, Aichi
Pfizer Investigational Site
Nagoya, Aichi, Japan
Pfizer Investigational Site
Okazaki-City, Aichi, Japan
Japan, Chiba
Pfizer Investigational Site
Kashiwa, Chiba, Japan
Japan, Ehime
Pfizer Investigational Site
Matsuyama-shi, Ehime, Japan
Japan, Gifu
Pfizer Investigational Site
Gifu-shi, Gifu, Japan
Japan, Hokkaido
Pfizer Investigational Site
Sapporo-shi, Hokkaido, Japan
Pfizer Investigational Site
Sapporo-shi, Hokkaido, Japan
Japan, Hyogo
Pfizer Investigational Site
Akashi, Hyogo, Japan
Japan, Kanagawa
Pfizer Investigational Site
Yokohama-city, Kanagawa, Japan
Pfizer Investigational Site
Yokohama, Kanagawa, Japan
Japan, Niigata
Pfizer Investigational Site
Niigata-shi, Niigata, Japan
Japan, Okayama
Pfizer Investigational Site
Okayama-city, Okayama, Japan
Japan, Osaka
Pfizer Investigational Site
Habikino-shi, Osaka, Japan
Pfizer Investigational Site
Osakasayama-shi, Osaka, Japan
Pfizer Investigational Site
Osaka-city, Osaka, Japan
Pfizer Investigational Site
Osaka-city, Osaka, Japan
Japan, Osaka-fu
Pfizer Investigational Site
Sakai-shi, Osaka-fu, Japan
Japan, Shizuoka
Pfizer Investigational Site
Sunto-gun, Shizuoka, Japan
Japan, Tokyo
Pfizer Investigational Site
Chuo-Ku, Tokyo, Japan
Japan, Yamaguchi
Pfizer Investigational Site
Ube-shi, Yamaguchi, Japan
Korea, Republic of
Pfizer Investigational Site
Seoul, Korea, Republic of, 110-744
Pfizer Investigational Site
Seoul, Korea, Republic of, 135-710
Pfizer Investigational Site
Gyeonggi-do, Korea, Republic of, 410-769
Pfizer Investigational Site
Seoul, Korea, Republic of, 138-736
Poland
Pfizer Investigational Site
Warszawa, Poland, 02-781
Pfizer Investigational Site
Warszawa, Poland, 01-138
Pfizer Investigational Site
Krakow, Poland, 31-115
Pfizer Investigational Site
Siedlce, Poland, 08-110
Pfizer Investigational Site
Warszawa, Poland, 02-097
Pfizer Investigational Site
Wroclaw, Poland, 53-439
Pfizer Investigational Site
Gdansk, Poland, 80-952
Puerto Rico
Pfizer Investigational Site
Ponce, Puerto Rico, 00716
Pfizer Investigational Site
Manatí, Puerto Rico, 00674
Pfizer Investigational Site
San Juan, Puerto Rico, 00917
Pfizer Investigational Site
San Juan, Puerto Rico, 00935
Russian Federation
Pfizer Investigational Site
St-Petersburg, Russian Federation, 194044
Pfizer Investigational Site
St. Petersburg, Russian Federation, 198255
Pfizer Investigational Site
Sochi, Russian Federation, 354057
Pfizer Investigational Site
Moscow, Russian Federation, 115478
Pfizer Investigational Site
Moscow, Russian Federation, 111033
Pfizer Investigational Site
Saint-Petersburg, Russian Federation, 197089
Pfizer Investigational Site
Samara, Russian Federation, 443066
Slovakia
Pfizer Investigational Site
Nitra-Zobor, Slovakia, 949 88
Pfizer Investigational Site
Nove Zamky, Slovakia, 94034
Pfizer Investigational Site
Kosice, Slovakia, 041 90
Pfizer Investigational Site
Poprad, Slovakia, 058 01
Spain
Pfizer Investigational Site
Cordoba, Spain, 14004
Pfizer Investigational Site
Madrid, Spain, 28033
Pfizer Investigational Site
Valencia, Spain, 46010
Spain, BARCELONA
Pfizer Investigational Site
L'hospitalet de Llobregat, BARCELONA, Spain, 08907
Spain, CANTABRIA
Pfizer Investigational Site
Santander, CANTABRIA, Spain, 39008
Spain, NAVARRA
Pfizer Investigational Site
Pamplona, NAVARRA, Spain, 31008
Switzerland
Pfizer Investigational Site
Zuerich, Switzerland, 8091
Pfizer Investigational Site
Fribourg, Switzerland, 1708
Taiwan
Pfizer Investigational Site
Taipei, Taiwan, 112
Pfizer Investigational Site
Taichung, Taiwan, 40705
Pfizer Investigational Site
Tainan, Taiwan, 704
Pfizer Investigational Site
Taipei, Taiwan, 100
Pfizer Investigational Site
Taipei, Taiwan, 114
Taiwan, Kaohsiung Hsien
Pfizer Investigational Site
Niao Sung Hsiang, Kaohsiung Hsien, Taiwan, 833
Turkey
Pfizer Investigational Site
Ankara, Turkey, 06100
Pfizer Investigational Site
Adana, Turkey, 01330
Pfizer Investigational Site
Ankara, Turkey, 06500
Turkey, Ankara
Pfizer Investigational Site
Sihhiye, Ankara, Turkey, 06100
Ukraine
Pfizer Investigational Site
Sumy, Ukraine, 40005
Pfizer Investigational Site
Kyiv, Ukraine, 03115
Pfizer Investigational Site
Dnipropetrovsk, Ukraine, 49102
Pfizer Investigational Site
Donetsk, Ukraine, 83092
Pfizer Investigational Site
Lviv, Ukraine, 79031
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
No publications provided

Responsible Party: Pfizer, Inc. ( Director, Clinical Trial Disclosure Group )
Study ID Numbers: A4021016
Study First Received: January 3, 2008
Last Updated: November 11, 2009
ClinicalTrials.gov Identifier: NCT00596830     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Pfizer:
IGF-1R inhibitor
Non-small-cell lung carcinoma
CP-751871

Additional relevant MeSH terms:
Thoracic Neoplasms
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Neoplasms by Site
Respiratory Tract Diseases
Lung Neoplasms
Therapeutic Uses
Neoplasms, Squamous Cell
Respiratory Tract Neoplasms
Neoplasms by Histologic Type
Mitosis Modulators
Carboplatin
Antimitotic Agents
Pharmacologic Actions
Carcinoma
Neoplasms
Paclitaxel
Lung Diseases
Carcinoma, Large Cell
Tubulin Modulators
Carcinoma, Squamous Cell
Antineoplastic Agents, Phytogenic
Carcinoma, Adenosquamous
Carcinoma, Non-Small-Cell Lung
Neoplasms, Complex and Mixed
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on November 25, 2009